|
Video: What is a Stock Split?
|
|
Novus Therapeutics is a pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat. Co. has two platform technologies, a surfactant and a foam. Co.'s primary program, OP0201, is a surfactant-based nasal aerosol drug-device combination product candidate being developed as a treatment option for patients at risk for, or with, otitis media (OM). OM is defined as middle ear inflammation and effusion with or without infection. Co. also has a foam-based drug delivery technology platform, which may be developed to deliver drugs into the ear, nasal, and sinus cavities. According to our NVUS stock split history records, NVUS has had 2 splits. | |
|
NVUS (NVUS) has 2 splits in our NVUS stock split history database. The first split for NVUS took place on May 11, 2017. This was a 1 for 9 reverse split, meaning for each 9 shares of NVUS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 111.111111111111 share position following the split. NVUS's second split took place on October 05, 2020. This was a 1 for 18 reverse split, meaning for each 18 shares of NVUS owned pre-split, the shareholder now owned 1 share. For example, a 111.111111111111 share position pre-split, became a 6.17283950617284 share position following the split.
When a company such as NVUS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the NVUS stock split history from start to finish, an original position size of 1000 shares would have turned into 6.17283950617284 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into NVUS shares, starting with a $10,000 purchase of NVUS, presented on a split-history-adjusted basis factoring in the complete NVUS stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/18/2014 |
|
End date: |
01/04/2021 |
|
Start price/share: |
$3,202.74 |
|
End price/share: |
$14.60 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.54% |
|
Average Annual Total Return: |
-57.49% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$45.60 |
|
Years: |
6.30 |
|
|
|
Date |
Ratio |
05/11/2017 | 1 for 9 | 10/05/2020 | 1 for 18 |
|
|